Stay updated on Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial
Sign up to get notified when there's something new on the Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial page.

Latest updates to the Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with a similar phrase.SummaryDifference0.9%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check110 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
Stay in the know with updates to Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial page.